header logo
ball drop image
ball drop image

Financial Capital

In an endeavour towards The Company generates financial capital annually in the form of surplus, arising from the current business operations, financing activities and investing activities through monetisation of assets and investments. We follow asset light model which allows us to generate rich cash and cash equivalents. Our 91.5% of the centre network and 16.1% lab network do not require capital and hence are asset light. During the year, we initiated cost rationalisation measures and have been successful in reducing fixed and semi-variable costs.

capital icon

Performance Highlights


(₹ in crores)

revenue gif image


(₹ in crores)

ebidta gif image


(₹ in crores)

Pat gif image

PAT before CSR, one-time share based and other expenses

(₹ in crores)

PAT before CSR gif image

Cash & Cash Equivalents

(₹ in crores)

Cash gif image



Patient gif image

Number of tests


tests gif image

Revenue per Patient

Revenue gif image

Revenue per Test

Test gif image

A growth of 100 bps B2C Sales Contribution

1.25 Crores,

Capex towards setting up Covid-19 Testing Facilities


Redcuction in fixed and and semi-Variable Costs

fc_inr image